Skip to main content
Premium Trial:

Request an Annual Quote

Sorenson Expands Labs, Stocks Genomics Tool Shed in Effort to Increase DNA Testing Capacity Five-Fold

NEW YORK (GenomeWeb News) - Sorenson Genomics said today it is expanding its laboratory facilities, boosting its staff, and expanding its genomics technology stock with new sequencers and sample-prep tools in a move to increase its DNA testing capacity by five-fold.
Sorenson said in a statement that it is expanding its capacity in order to meet “sharply increasing demand” for its DNA testing services.
Sorenson Genomics' chief operating officer, Douglas Fogg, told GenomeWeb Daily News that the Salt Lake City-based company plans to expand its laboratory space from 10,000 square feet to a total of 15,000 sq. ft., and its office space from 3,500 sq. ft. to 5,500 sq. ft.
Fogg also said the company plans to expand its hardware by buying three new Applied Biosystems 3730 genetic analyzers, two Beckman Coulter BioMek FX liquid-handling instruments, and one automated DNA-extraction tool.
Fogg also said Sorenson plans to increase its staff by about 25 percent, adding roughly 20 new staffers to its expanded lab.
The company is split into four segments: GeneTree, a provider of on-line paternity testing services; Identigene, a PCR-based DNA testing company; Sorenson Forensics, which provides forensic casework services; and Sorenson Genomics, which provides DNA testing services to worldwide resellers.
Fogg said the expansions will affect Sorenson's Forensics, GeneTree, and Genomics divisions. The expansions will not affect its Houston-based Identigene division, which it acquired in June.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more